
    
      Study design : The study is designed as a double-blind placebo controlled study for 3 months
      followed by a pseudo cross-over such that all subjects receiving placebo the first 3 months
      will receive active drug the second 3 months and all receiving naltrexone the first 3 months
      remain on the drug the last 3 months of this 6 month study.
    
  